Literature DB >> 24389010

Increased l1 retrotransposition in the neuronal genome in schizophrenia.

Miki Bundo1, Manabu Toyoshima2, Yohei Okada3, Wado Akamatsu3, Junko Ueda4, Taeko Nemoto-Miyauchi4, Fumiko Sunaga5, Michihiro Toritsuka6, Daisuke Ikawa6, Akiyoshi Kakita7, Motoichiro Kato8, Kiyoto Kasai9, Toshifumi Kishimoto6, Hiroyuki Nawa10, Hideyuki Okano3, Takeo Yoshikawa2, Tadafumi Kato11, Kazuya Iwamoto12.   

Abstract

Recent studies indicate that long interspersed nuclear element-1 (L1) are mobilized in the genome of human neural progenitor cells and enhanced in Rett syndrome and ataxia telangiectasia. However, whether aberrant L1 retrotransposition occurs in mental disorders is unknown. Here, we report high L1 copy number in schizophrenia. Increased L1 was demonstrated in neurons from prefrontal cortex of patients and in induced pluripotent stem (iPS) cell-derived neurons containing 22q11 deletions. Whole-genome sequencing revealed brain-specific L1 insertion in patients localized preferentially to synapse- and schizophrenia-related genes. To study the mechanism of L1 transposition, we examined perinatal environmental risk factors for schizophrenia in animal models and observed an increased L1 copy number after immune activation by poly-I:C or epidermal growth factor. These findings suggest that hyperactive retrotransposition of L1 in neurons triggered by environmental and/or genetic risk factors may contribute to the susceptibility and pathophysiology of schizophrenia.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24389010     DOI: 10.1016/j.neuron.2013.10.053

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  131 in total

Review 1.  Induced pluripotent stem cells for modeling neurological disorders.

Authors:  Fabiele B Russo; Fernanda R Cugola; Isabella R Fernandes; Graciela C Pignatari; Patricia C B Beltrão-Braga
Journal:  World J Transplant       Date:  2015-12-24

Review 2.  Somatic DNA Variation in Brain as a Source of Risk for CNS Diseases.

Authors:  Glenn A Doyle; Wade H Berrettini
Journal:  Neuropsychopharmacology       Date:  2016-01       Impact factor: 7.853

3.  An Atypical AAA+ ATPase Assembly Controls Efficient Transposition through DNA Remodeling and Transposase Recruitment.

Authors:  Ernesto Arias-Palomo; James M Berger
Journal:  Cell       Date:  2015-08-13       Impact factor: 41.582

Review 4.  Retrotransposons as regulators of gene expression.

Authors:  Reyad A Elbarbary; Bronwyn A Lucas; Lynne E Maquat
Journal:  Science       Date:  2016-02-11       Impact factor: 47.728

Review 5.  Stress and the dynamic genome: Steroids, epigenetics, and the transposome.

Authors:  Richard G Hunter; Khatuna Gagnidze; Bruce S McEwen; Donald W Pfaff
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

6.  TEtranscripts: a package for including transposable elements in differential expression analysis of RNA-seq datasets.

Authors:  Ying Jin; Oliver H Tam; Eric Paniagua; Molly Hammell
Journal:  Bioinformatics       Date:  2015-07-23       Impact factor: 6.937

7.  Using Induced Pluripotent Stem Cells to Investigate Complex Genetic Psychiatric Disorders.

Authors:  Stephanie J Temme; Brady J Maher; Kimberly M Christian
Journal:  Curr Behav Neurosci Rep       Date:  2016-10-14

Review 8.  Hydrogen sulfide signalling in the CNS - Comparison with NO.

Authors:  Hideo Kimura
Journal:  Br J Pharmacol       Date:  2020-09-20       Impact factor: 8.739

9.  Transposable element dysregulation in systemic lupus erythematosus and regulation by histone conformation and Hsp90.

Authors:  Maurer Kelly; Shi Lihua; Zhang Zhe; Song Li; Paucar Yoselin; Petri Michelle; E Sullivan Kathleen
Journal:  Clin Immunol       Date:  2018-08-24       Impact factor: 3.969

10.  Analysis of conditional heterozygous STXBP1 mutations in human neurons.

Authors:  Christopher Patzke; Yan Han; Jason Covy; Fei Yi; Stephan Maxeiner; Marius Wernig; Thomas C Südhof
Journal:  J Clin Invest       Date:  2015-08-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.